- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07563725
Vascular Aging and Microcirculation: Physiological Aspects of Vascular Aging in the Elderly Population (VAMP-Aging) (VAMP-Aging)
Rising life expectancy worldwide challenges public health due to increased cardiovascular disease linked to vascular aging, where microvascular dysfunction serves as an early indicator of system-wide inflammation, or "inflammaging". The proposed study aims to validate non-invasive, high-resolution techniques, such as Laser Speckle Contrast Imaging, to identify early endothelial senescence biomarkers and map their correlation with metabolic, inflammatory, and anthropometric profiles to advance personalized, preventive translational medicine.
Studienübersicht
Status
Bedingungen
Detaillierte Beschreibung
An observational, cross-sectional study will be conducted, including volunteers aged ≥ 60 years, divided into two groups: elderly (60-80 years) and very elderly (>80). Young volunteers aged between 20 and 40 years, already participants in previous studies, whose demographic and microcirculation data are in the research laboratory's database, will be included as controls. Data from the control group will be obtained from an institutional database, respecting confidentiality and anonymization, in accordance with current ethical standards.
Studientyp
Einschreibung (Geschätzt)
Kontakte und Standorte
Studienkontakt
- Name: Eduardo Tibirica, MD, PhD
- Telefonnummer: +55-21-99914-6075
- E-Mail: etibi@uol.com.br
Studienorte
-
-
-
Rio de Janeiro, Brasilien, 22240006
- Rekrutierung
- Eduardo Tibiriçá
-
Kontakt:
- Eduardo Tibiriçá, MD, PhD
- Telefonnummer: 21999146075
- E-Mail: etibi@oul.com.br
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
An observational, cross-sectional study will be conducted, including volunteers aged ≥ 60 years, divided into two groups: elderly (60-80 years) and very elderly (>80). Young volunteers aged between 20 and 40 years, already participants in previous studies, whose demographic and microcirculation data are in the research laboratory's database, will be included as controls. Data from the control group will be obtained from an institutional database, respecting confidentiality and anonymization, in accordance with current ethical standards.
Beschreibung
Inclusion Criteria:
- Absence of symptoms and history of cardiovascular and cerebrovascular diseases.
- Baseline blood pressure levels within the normal range (< 140/90 mmHg, according to WHO criteria) and absence of use of antihypertensive medications.
Exclusion Criteria:
- Diabetes Mellitus: Fasting blood glucose ≥ 126 mg/dL or use of hypoglycemic agents.
- Smoking: Active or quit less than 5 years ago.
- Inflammatory Diseases: Autoimmune diseases, active neoplasms, or acute infectious processes.
- Surgery or trauma in the last 60 days.
- Renal Dysfunction: Chronic renal failure (estimated by eGFR < 60 mL/min/1.73m²).
- Medication Use: Chronic use of corticosteroids, immunosuppressants, or drugs with direct action on vascular reactivity (e.g., continuous use of nitrates).
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Beobachtungsmodelle: COHORT
- Zeitperspektiven: PROSPECTIVE
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
|---|---|
|
elderly (60-80 years)
Evaluation of systemic microcirculation Cognitive assessment tests Muscle strength assessment tests Life history and health questionnaire |
Investigation of Systemic Endothelial Microvascular Function Serving as a marker of systemic muscle strength and sarcopenia. This test will assess the strength and power of the lower limbs. Failure to maintain the position (to stand on one leg) for at least 10 seconds will be correlated as a marker of frailty and risk of falls. Overall cognitive function will be assessed using the Mini-Mental State Examination. |
|
very elderly (>80)
Evaluation of systemic microcirculation Cognitive assessment tests Muscle strength assessment tests Life history and health questionnaire |
Investigation of Systemic Endothelial Microvascular Function Serving as a marker of systemic muscle strength and sarcopenia. This test will assess the strength and power of the lower limbs. Failure to maintain the position (to stand on one leg) for at least 10 seconds will be correlated as a marker of frailty and risk of falls. Overall cognitive function will be assessed using the Mini-Mental State Examination. |
|
control group: healthy young people aged 20-40 years
Evaluation of systemic microcirculation Cognitive assessment tests Muscle strength assessment tests Life history and health questionnaire |
Investigation of Systemic Endothelial Microvascular Function Serving as a marker of systemic muscle strength and sarcopenia. This test will assess the strength and power of the lower limbs. Failure to maintain the position (to stand on one leg) for at least 10 seconds will be correlated as a marker of frailty and risk of falls. Overall cognitive function will be assessed using the Mini-Mental State Examination. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Systemic (cutaneous) microcirculatory reactivity.
Zeitfenster: up to 20 minutes
|
To analyze structural and functional changes in the microcirculation in different ages groups, with emphasis on microvascular endothelial senescence. |
up to 20 minutes
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Muscle Strength
Zeitfenster: up to 10 minutes
|
Handgrip Dynamometry Maximum isometric strength will be assessed using a manual hydraulic dynamometer. |
up to 10 minutes
|
Mitarbeiter und Ermittler
Ermittler
- Hauptermittler: Eduardo Tibirica, MD, PhD, National Institute of Cardiology/Ministry of Health
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- VAMP-Aging
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .